| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,687 |
5,044 |
$278K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,102 |
3,106 |
$128K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,724 |
3,036 |
$107K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
11,118 |
7,501 |
$41K |
| 82948 |
|
565 |
356 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
48 |
31 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
97 |
52 |
$1K |
| 90832 |
Psychotherapy, 30 minutes with patient |
45 |
31 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
316 |
246 |
$930.36 |
| 36415 |
Collection of venous blood by venipuncture |
102 |
64 |
$905.48 |
| 99215 |
Prolong outpt/office vis |
22 |
12 |
$837.68 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
43 |
12 |
$682.76 |
| 81000 |
|
71 |
44 |
$425.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$324.95 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
71 |
66 |
$248.51 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49 |
38 |
$211.06 |
| 99442 |
|
25 |
14 |
$175.68 |
| 0013A |
|
15 |
14 |
$139.89 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
152 |
58 |
$51.31 |
| 0012A |
|
136 |
80 |
$35.87 |
| 0011A |
|
211 |
128 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
33 |
26 |
$0.00 |
| 91301 |
|
263 |
186 |
$0.00 |
| 3074F |
|
37 |
37 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
47 |
44 |
$0.00 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
20 |
12 |
$0.00 |
| 90686 |
|
16 |
16 |
$0.00 |
| 1160F |
|
45 |
42 |
$0.00 |
| 1159F |
|
44 |
41 |
$0.00 |
| 81003 |
|
81 |
69 |
$0.00 |
| 3725F |
|
29 |
26 |
$0.00 |
| 81002 |
|
19 |
12 |
$0.00 |
| 3078F |
|
15 |
12 |
$0.00 |